Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) was $4.20 for the day, up 1.94% from the previous closing price of $4.12. In other words, the price has increased by $1.94 from its previous closing price. On the day, 1.58 million shares were traded. MRVI stock price reached its highest trading level at $4.34 during the session, while it also had its lowest trading level at $4.1.
Ratios:
Our analysis of MRVI’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 9.94 and its Current Ratio is at 10.74. In the meantime, Its Debt-to-Equity ratio is 1.63 whereas as Long-Term Debt/Eq ratio is at 1.59.
On December 05, 2024, Goldman Downgraded its rating to Sell which previously was Neutral but kept the price unchanged to $4.25.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 31 ’25 when ORESHACK KURT sold 25,000 shares for $5.03 per share. The transaction valued at 125,750 led to the insider holds 167,618 shares of the business.
ORESHACK KURT bought 25,000 shares of MRVI for $125,750 on Jan 31 ’25. On Nov 12 ’24, another insider, DeFord John A, who serves as the Director of the company, bought 17,500 shares for $5.75 each. As a result, the insider paid 100,625 and bolstered with 70,046 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRVI now has a Market Capitalization of 1060617536 and an Enterprise Value of 898915712. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.15 while its Price-to-Book (P/B) ratio in mrq is 1.72. Its current Enterprise Value per Revenue stands at 3.246 whereas that against EBITDA is 867.679.
Stock Price History:
The Beta on a monthly basis for MRVI is -0.08, which has changed by -0.21052629 over the last 52 weeks, in comparison to a change of 0.22894537 over the same period for the S&P500. Over the past 52 weeks, MRVI has reached a high of $11.56, while it has fallen to a 52-week low of $4.05. The 50-Day Moving Average of the stock is -19.37%, while the 200-Day Moving Average is calculated to be -43.65%.
Shares Statistics:
MRVI traded an average of 1.90M shares per day over the past three months and 2016160 shares per day over the past ten days. A total of 141.59M shares are outstanding, with a floating share count of 117.86M. Insiders hold about 16.90% of the company’s shares, while institutions hold 86.90% stake in the company. Shares short for MRVI as of 1738281600 were 8540093 with a Short Ratio of 4.48, compared to 1735603200 on 8507989. Therefore, it implies a Short% of Shares Outstanding of 8540093 and a Short% of Float of 7.180000000000001.
